CUSTOPHARM INC FDA Approval NDA 214253

NDA 214253

CUSTOPHARM INC

FDA Drug Application

Application #214253

Documents

Letter2021-05-18
Label2021-05-18

Application Sponsors

NDA 214253CUSTOPHARM INC

Marketing Status

Prescription001

Application Products

001SOLUTION;INTRAVENOUS100MCG/ML2LEVOTHYROXINE SODIUMLEVOTHYROXINE SODIUM

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2021-05-17STANDARD

Submissions Property Types

ORIG1Null6

TE Codes

001None (Tentative Approval)TBD

CDER Filings

CUSTOPHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214253
            [companyName] => CUSTOPHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVOTHYROXINE SODIUM","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"100MCG\/ML","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
            [labels] => [{"actionDate":"05\/17\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/214253s000lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"05\/17\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 5 - New Formulation or New Manufacturer","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/214253s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214253Orig1s000ltr.pdf\"}]","notes":">"}]
            [supplements] => 
            [actionDate] => 2021-05-17
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.